Cover
Cover | Oct. 12, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Current Report on Form 8-K/A is being filed to furnish an updated version of the Investor Presentation furnished as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed earlier on October 12, 2022. As used herein and unless otherwise indicated, the terms “the Company,” “Organicell,” “we,” “us” and “our” refer to Organicell Regenerative Medicine, Inc. and its subsidiaries. |
Document Period End Date | Oct. 12, 2022 |
Entity File Number | 000-55008 |
Entity Registrant Name | ORGANICELL REGENERATIVE MEDICINE, INC. |
Entity Central Index Key | 0001557376 |
Entity Tax Identification Number | 47-4180540 |
Entity Incorporation, State or Country Code | NV |
Entity Address, Address Line One | 3321 College Avenue |
Entity Address, Address Line Two | Suite 246 |
Entity Address, City or Town | Davie |
Entity Address, State or Province | FL |
Entity Address, Postal Zip Code | 33314 |
City Area Code | (888) |
Local Phone Number | 963-7881 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |